835
Views
8
CrossRef citations to date
0
Altmetric
Report

Tumorigenicity analysis of heterogeneous dental stem cells and its self-modification for chromosome instability

, , , , , , , & show all
Pages 3396-3407 | Received 19 Dec 2014, Accepted 26 Mar 2015, Published online: 13 Nov 2015

References

  • Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B, Robertson M, Vrana J, Jones K, Grotewold L, Smith A. Nanog safeguards pluripotency and mediates germline development. Nature 2007; 450:1230-4; PMID:18097409; http://dx.doi.org/10.1038/nature06403
  • Hayashi K, Lopes SM, Tang F, Surani MA. Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Sell 2008; 3:391-401; PMID:18940731; http://dx.doi.org/10.1016/j.stem.2008.07.027
  • Singh AM, Hamazaki T, Hankowski KE, Terada N. A heterogeneous expression pattern for Nanog in embryonic stem cells. Stem cells 2007; 25:2534-42; PMID:17615266; http://dx.doi.org/10.1634/stemcells.2007-0126
  • Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001; 19:180-92; PMID:11359943; http://dx.doi.org/10.1634/stemcells.19-3-180
  • Graf T, Stadtfeld M. Heterogeneity of embryonic and adult stem cells. Cell Stem Cell 2008; 3:480-3; PMID:18983963; http://dx.doi.org/10.1016/j.stem.2008.10.007
  • Solozobova V, Blattner C. p53 in stem cells. World J Biol Chem 2011; 2:202-14; PMID:21949570; http://dx.doi.org/10.4331/wjbc.v2.i9.202
  • Valtieri M, Sorrentino A. The mesenchymal stromal cell contribution to homeostasis. J Cell Physiol 2008; 217:296-300; PMID:18615579; http://dx.doi.org/10.1002/jcp.21521
  • Chery L, Lam HM, Coleman I, Lakely B, Coleman R, Larson S, Aguirre-Ghiso JA, Xia J, Gulati R, Nelson PS, et al. Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways. Oncotarget 2014; 5:9939-51; PMID:25301725
  • Boesch M, Zeimet AG, Reimer D, Schmidt S, Gastl G, Parson W, Spoeck F, Hatina J, Wolf D, Sopper S. The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics. Oncotarget 2014; 5:7027-39; PMID:25216521
  • Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011; 11:268-77; PMID:21390058; http://dx.doi.org/10.1038/nrc3034
  • Bolouri H. Network dynamics in the tumor microenvironment. Semin Cancer Biol 2014; 30:52-9; PMID: 24582766; http://dx.doi.org/10.1016/j.semcancer.2014.02.007
  • Biancotti JC, Benvenisty N. Aneuploid human embryonic stem cells: origins and potential for modeling chromosomal disorders. Regenerative Med 2011; 6:493-503; PMID:21749207; http://dx.doi.org/10.2217/rme.11.27
  • Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7:521-31; PMID:20887957; http://dx.doi.org/10.1016/j.stem.2010.07.017
  • Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, Seo BM, Sonoyama W, Zheng JJ, Baker CC, et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 2006; 24:1095-103; PMID:16282438; http://dx.doi.org/10.1634/stemcells.2005-0403
  • Boveri T. Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci 2008; 121 Suppl 1:1-84; PMID:18089652; http://dx.doi.org/10.1242/jcs.025742
  • A SA, H BC, J SS. Application of UV-spectrophotometric methods for estimation of tenofovir disoproxil fumarate in tablets. Pakistan J Pharm Sci 2009; 22:27-9; PMID:19168416;
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
  • Moon SH, Kim JS, Park SJ, Lim JJ, Lee HJ, Lee SM, Chung HM. Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo. Stem Cell Res 2011; 6:50-9; PMID:20920899; http://dx.doi.org/10.1016/j.scr.2010.08.006
  • Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 2001; 98:7841-5; PMID:11427725; http://dx.doi.org/10.1073/pnas.141221698
  • Guo W, Gong K, Shi H, Zhu G, He Y, Ding B, Wen L, Jin Y. Dental follicle cells and treated dentin matrix scaffold for tissue engineering the tooth root. Biomaterials 2012; 33:1291-302; PMID:22088889; http://dx.doi.org/10.1016/j.biomaterials.2011.09.068
  • Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000; 113 (Pt 7)1161-6; PMID:10704367;
  • Lee CC, Christensen JE, Yoder MC, Tarantal AF. Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells. Exp Hematol 2010; 38:46-54; PMID:19900502; http://dx.doi.org/10.1016/j.exphem.2009.11.001
  • Yoshimura K, Asano Y, Aoi N, Kurita M, Oshima Y, Sato K, Inoue K, Suga H, Eto H, Kato H, et al. Progenitor-enriched adipose tissue transplantation as rescue for breast implant complications. Breast J 2010; 16:169-75; PMID:19912236; http://dx.doi.org/10.1111/j.1524-4741.2009.00873.x
  • Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, Partridge TA, Morgan JE. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005; 122:289-301; PMID:16051152; http://dx.doi.org/10.1016/j.cell.2005.05.010
  • Sherwood RI, Christensen JL, Conboy IM, Conboy MJ, Rando TA, Weissman IL, Wagers AJ. Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 2004; 119:543-54; PMID:15537543; http://dx.doi.org/10.1016/j.cell.2004.10.021
  • Yang R, Chen M, Lee CH, Yoon R, Lal S, Mao JJ. Clones of ectopic stem cells in the regeneration of muscle defects in vivo. PloS One 2010; 5:e13547; PMID: 20975999; http://dx.doi.org/10.1371/journal.pone.0013547
  • Wagner W, Feldmann RE Jr, Seckinger A, Maurer MH, Wein F, Blake J, Krause U, Kalenka A, Burgers HF, Saffrich R, et al. The heterogeneity of human mesenchymal stem cell preparations-evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol 2006; 34:536-48; PMID:16569600; http://dx.doi.org/10.1016/j.exphem.2006.01.002
  • Guo W, Chen L, Gong K, Ding B, Duan Y, Jin Y. Heterogeneous dental follicle cells and the regeneration of complex periodontal tissues. Tissue Eng Part A 2012; 18:459-70; PMID:21919800; http://dx.doi.org/10.1089/ten.TEA.2011.0261
  • Hou LT, Liu CM, Chen YJ, Wong MY, Chen KC, Chen J, Thomas HF. Characterization of dental follicle cells in developing mouse molar. Arch Oral Biol 1999; 44:759-70; PMID:10471160;
  • Wu J, Jin F, Tang L, Yu J, Xu L, Yang Z, Wu G, Duan Y, Jin Y. Dentin non-collagenous proteins (dNCPs) can stimulate dental follicle cells to differentiate into cementoblast lineages. Biol Cell/Under Auspices Eur Cell Biol Organ 2008; 100:291-302; PMID:18042041; http://dx.doi.org/10.1042/BC20070092
  • Yao S, Pan F, Prpic V, Wise GE. Differentiation of stem cells in the dental follicle. J Dental Res 2008; 87:767-71; PMID:18650550;
  • Kabir R, Gupta M, Aggarwal A, Sharma D, Sarin A, Kola MZ. Imperative role of dental pulp stem cells in regenerative therapies: a systematic review. Nigerian J Surg: Off Pub Nigerian Surg Res Soc 2014; 20:1-8; PMID:24665194; http://dx.doi.org/10.4103/1117-6806.127092
  • Lymperi S, Ligoudistianou C, Taraslia V, Kontakiotis E, Anastasiadou E. Dental stem cells and their applications in dental tissue engineering. Open Dent J 2013; 7:76-81; PMID:24009647; http://dx.doi.org/10.2174/1874210601307010076
  • Insinga A, Cicalese A, Faretta M, Gallo B, Albano L, Ronzoni S, Furia L, Viale A, Pelicci PG. DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions. Proc Natl Acad Sci U S Am 2013; 110:3931-6; PMID:23417300; http://dx.doi.org/10.1073/pnas.1213394110
  • Udayakumar T, Shareef MM, Diaz DA, Ahmed MM, Pollack A. The E2F1/Rb and p53/MDM2 pathways in DNA repair and apoptosis: understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy. Semin Radiat Oncol 2010; 20:258-66; PMID:20832018; http://dx.doi.org/10.1016/j.semradonc.2010.05.007
  • Schvartzman JM, Duijf PH, Sotillo R, Coker C, Benezra R. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 2011; 19:701-14; PMID:21665145; http://dx.doi.org/10.1016/j.ccr.2011.04.017
  • Ryan SD, Britigan EM, Zasadil LM, Witte K, Audhya A, Roopra A, Weaver BA. Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons. Proc Natl Acad Sci U S A 2012; 109:E2205-14; PMID:22778409; http://dx.doi.org/10.1073/pnas.1201911109
  • Schvartzman JM, Sotillo R, Benezra R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 2010; 10:102-15; PMID:20094045; http://dx.doi.org/10.1038/nrc2781
  • El-Sayed KM, Paris S, Graetz C, Kassem N, Mekhemar M, Ungefroren H, Fandrich F, Dorfer C. Isolation and characterisation of human gingival margin-derived STRO-1/MACS and MACS cell populations. Int J Oral Sci 2014; 7:80-8; PMID:25257881; http://dx.doi.org/10.1038/ijos.2014.41
  • Xu J, Wang W, Kapila Y, Lotz J, Kapila S. Multiple differentiation capacity of STRO-1+/CD146+ PDL mesenchymal progenitor cells. Stem Cells Dev 2009; 18:487-96; PMID:18593336; http://dx.doi.org/10.1089/scd.2008.0113
  • Majore I, Moretti P, Hass R, Kasper C. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signaling: CCS 2009; 7:6; PMID:19302702; http://dx.doi.org/10.1186/1478-811X-7-6
  • Stewart MH, Bosse M, Chadwick K, Menendez P, Bendall SC, Bhatia M. Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Nat Methods 2006; 3:807-15; PMID:16990813; http://dx.doi.org/10.1038/nmeth939
  • Sengers BG, Dawson JI, Oreffo RO. Characterisation of human bone marrow stromal cell heterogeneity for skeletal regeneration strategies using a two-stage colony assay and computational modelling. Bone 2010; 46:496-503; PMID:19818885; http://dx.doi.org/10.1016/j.bone.2009.10.002
  • Tormin A, Brune JC, Olsson E, Valcich J, Neuman U, Olofsson T, Jacobsen SE, Scheding S. Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profiling of functionally defined MSC subsets. Cytotherapy 2009; 11:114-28; PMID:19242838; http://dx.doi.org/10.1080/14653240802716590
  • Smith JG, Smith AJ, Shelton RM, Cooper PR. Recruitment of dental pulp cells by dentine and pulp extracellular matrix components. Exp Cell Res 2012; 318:2397-406; PMID:22819733; http://dx.doi.org/10.1016/j.yexcr.2012.07.008
  • Freedman DA, Wu L, Levine AJ. Functions of the MDM2 oncoprotein. Cell Mol Life Sci: CMLS 1999; 55:96-107; PMID:10065155
  • Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005; 437:1043-7; PMID:16222300; http://dx.doi.org/10.1038/nature04217
  • Heng HH, Bremer SW, Stevens JB, Horne SD, Liu G, Abdallah BY, Ye KJ, Ye CJ. Chromosomal instability (CIN) what it is and why it is crucial to cancer evolution. Cancer Metast Rev 2013; 32:325-40; PMID:23605440; http://dx.doi.org/10.1007/s10555-013-9427-7
  • Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8:275-83; PMID:17380161; http://dx.doi.org/10.1038/nrm2147
  • Notterman D, Young S, Wainger B, Levine AJ. Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity. Oncogene 1998; 17:2743-51; PMID:9840938; http://dx.doi.org/10.1038/sj.onc.1202210
  • Lee J, Hoi CS, Lilja KC, White BS, Lee SE, Shalloway D, Tumbar T. Runx1 and p21 synergistically limit the extent of hair follicle stem cell quiescence in vivo. Proc Natl Acad Sci U S Am 2013; 110:4634-9; PMID:23487742; http://dx.doi.org/10.1073/pnas.1213015110
  • Zielke N, Kim KJ, Tran V, Shibutani ST, Bravo MJ, Nagarajan S, van Straaten M, Woods B, von Dassow G, Rottig C, et al. Control of Drosophila endocycles by E2F and CRL4(CDT2). Nature 2011; 480:123-7; PMID:22037307; http://dx.doi.org/10.1038/nature10579
  • Lin WC, Lin FT, Nevins JR. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 2001; 15:1833-44; PMID:11459832
  • Maser RS, Mirzoeva OK, Wells J, Olivares H, Williams BR, Zinkel RA, Farnham PJ, Petrini JH. Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol 2001; 21:6006-16; PMID:11486038
  • Liu K, Lin FT, Ruppert JM, Lin WC. Regulation of E2F1 by BRCT domain-containing protein TopBP1. Mol Cell Biol 2003; 23:3287-304; PMID:12697828
  • Guo R, Chen J, Zhu F, Biswas AK, Berton TR, Mitchell DL, Johnson DG. E2F1 localizes to sites of UV-induced DNA damage to enhance nucleotide excision repair. J Biol Chem 2010; 285:19308-15; PMID:20413589; http://dx.doi.org/10.1074/jbc.M110.121939
  • Chen J, Zhu F, Weaks RL, Biswas AK, Guo R, Li Y, Johnson DG. E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks. Cell Cycle 2011; 10:1287-94; PMID:21512314; http://dx.doi.org/10.4161/cc.10.8.15341
  • Schuyler SC, Wu YF, Kuan VJ. The Mad1-Mad2 balancing act - a damaged spindle checkpoint in chromosome instability and cancer. J Cell Sci 2012; 125:4197-206; PMID:23093575; http://dx.doi.org/10.1242/jcs.107037
  • Bonizzi G, Cicalese A, Insinga A, Pelicci PG. The emerging role of p53 in stem cells. Trends Mol Med 2012; 18:6-12; PMID:21907001; http://dx.doi.org/10.1016/j.molmed.2011.08.002
  • Gregory CA, Gunn WG, Reyes E, Smolarz AJ, Munoz J, Spees JL, Prockop DJ. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Ann New York Acad Sci 2005; 1049:97-106; PMID:15965110; http://dx.doi.org/10.1196/annals.1334.010
  • Rosenbluh J, Wang X, Hahn WC. Genomic insights into WNT/beta-catenin signaling. Trends Pharmacol Sci 2014; 35:103-9; PMID:24365576; http://dx.doi.org/10.1016/j.tips.2013.11.007
  • James AW. Review of signaling pathways governing MSC osteogenic and adipogenic differentiation. Scientifica 2013; 2013:684736; PMID:24416618; http://dx.doi.org/10.1155/2013/684736
  • Heggebo J, Haasters F, Polzer H, Schwarz C, Saller MM, Mutschler W, Schieker M, Prall WC. Aged human mesenchymal stem cells: the duration of bone morphogenetic protein-2 stimulation determines induction or inhibition of osteogenic differentiation. Orthopedic Rev 2014; 6:5242; PMID:25002931; http://dx.doi.org/10.4081/or.2014.5242
  • Kevin A. Maupin CJD, Bart O. Williams. A comprehensive overview of skeletal phenotypes associated with alterations in Wnt/β-catenin signaling in humans and mice. Bone Res 2013; 1:27-71; PMID:http://dx.doi.org/10.4248/BR201301004

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.